Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RAB GTPase activating protein 1 is a member of the TBC-domain (Tre-2, Bub2, Cdc16) family of GAPs that regulate Rab GTPases, key orchestrators of intracellular membrane trafficking. These proteins accelerate the intrinsic GTP hydrolysis on Rab GTPases, converting them from active (GTP-bound) to inactive (GDP-bound) states, thereby temporally and spatially terminating Rab signaling and ensuring proper membrane traffic and organelle identity[1][2][4]. Rab-GAPs, via their TBC domains, exhibit specificity for Rabs and are integral to maintaining the fidelity of cellular transport pathways; loss of function or mutation can lead to trafficking defects in model organisms[2]. These are not direct drug targets but are essential for the proper regulation of Rab-mediated transport mechanisms. If you require information on a particular human Rab-GAP (e.g., TBC1D1), clarification with an exact gene/protein name will yield more precise, structured information.
Not applicable; no drugs currently target Rab GAPs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RAB GTPase activating protein 1 (RAB-GAP1).